Sort
130,381 grants matching “hiv”
Core J: Virology and Molecular Biomarkers Core
$813,884Guido Silvestri · Emory University · P30 · FY2019 · AI
Immune Dysfunction in HIV+ Opioid Users
$813,855Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2021 · DA
Imaging Virological Synapses During Parenteral HIV Transmission
$813,854Benjamin K Chen · Icahn School Of Medicine At Mount Sinai · DP1 · FY2011 · DA
Imaging Virological Synapses During Parenteral HIV Transmission
$813,854Benjamin K Chen · Icahn School Of Medicine At Mount Sinai · DP1 · FY2012 · DA
Glutamine metabolism inhibitors for TB and TB-HIV: dual action as host-directed therapies with antibacterial activity
$813,838William Ramses Bishai · Johns Hopkins University · R01 · FY2021 · AI
Glutamine metabolism inhibitors for TB and TB-HIV: dual action as host-directed therapies with antibacterial activity
$813,838William Ramses Bishai · Johns Hopkins University · R01 · FY2022 · AI
Genetic and hormonal mechanisms mediating sex differences in TB and TB-HIV
$813,838William Ramses Bishai · Johns Hopkins University · R37 · FY2025 · AI
Genetic and hormonal mechanisms mediating sex differences in TB and TB-HIV
$813,838William Ramses Bishai · Johns Hopkins University · R37 · FY2023 · AI
Glutamine metabolism inhibitors for TB and TB-HIV: dual action as host-directed therapies with antibacterial activity
$813,838William Ramses Bishai · Johns Hopkins University · R01 · FY2024 · AI
Glutamine metabolism inhibitors for TB and TB-HIV: dual action as host-directed therapies with antibacterial activity
$813,838William Ramses Bishai · Johns Hopkins University · R01 · FY2023 · AI
Genetic and hormonal mechanisms mediating sex differences in TB and TB-HIV
$813,838William Ramses Bishai · Johns Hopkins University · R37 · FY2022 · AI
Identification of immune protective pathways dysregulated by opioid use in HIV infection, using a systems biology-based approach, toward the goal of pharmacological restoration of immune function
$813,788Alan David Levine · Case Western Reserve University · R01 · FY2017 · DA
Identification of immune protective pathways dysregulated by opioid use in HIV infection, using a systems biology-based approach, toward the goal of pharmacological restoration of immune function
$813,788Alan David Levine · Case Western Reserve University · R01 · FY2020 · DA
Identification of immune protective pathways dysregulated by opioid use in HIV infection, using a systems biology-based approach, toward the goal of pharmacological restoration of immune function
$813,788Alan David Levine · Case Western Reserve University · R01 · FY2016 · DA
Exploration, conservation, and development of marine bi*
$813,774Mark E Hay · Georgia Institute Of Technology · U01 · FY2006 · TW
Immune interventions in SIV-infected ART-suppressed infant macaques
$813,748Ann M Chahroudi · Emory University · R01 · FY2020 · AI
Pathogenic determinants of the SIV envelope transmembrane cytoplasmic domain
$813,747James A Hoxie · University Of Pennsylvania · R01 · FY2012 · AI
Fogarty AIDS International Training and Research Program (AITRP)
$813,746Chris Beyrer · Johns Hopkins University · D43 · FY2008 · TW
Structure and immunogenicity of novel trimeric HIV-1 Env immunogens
$813,635Xiangpeng Kong · New York University School Of Medicine · R01 · FY2019 · AI
Could long-acting medications facilitate âending AIDS by 2030â in southern Africa? An allocative efficiency analysis
$813,628Ronald Scott Braithwaite · New York University School Of Medicine · R01 · FY2019 · AA
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
$813,621Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Role of Macrophages in Lung Disease Pathogenesis of Pediatric AIDS
$813,621Marcelo J Kuroda · Tulane University Of Louisiana · R01 · FY2015 · HL
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
$813,598Jessica Robinson-Papp · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · DK
STUDIES OF NATURAL SIV INFECTION OF SOOTY MANGABEYS
$813,556Guido Silvestri · Emory University · R37 · FY2016 · AI
Cabotegravir PrEP: Actionable Robust Evidence for Translation into Practice (CABARET)
$813,488Julia L. Marcus · Harvard Pilgrim Health Care, Inc. · R01 · FY2023 · AI